Values of serum CA125, NSE and 24‐hour urine VMA in diagnosis and prediction of treatment of pediatric neuroblastoma

Author(s):  
Jinmin Li ◽  
Xiangyang Liu ◽  
Mo Chen ◽  
Jiachen Wang ◽  
Xinning Wang
Keyword(s):  
2021 ◽  
Vol 49 (1) ◽  
pp. 030006052098668
Author(s):  
Bo Pang ◽  
Cong Hu ◽  
Qian Liu ◽  
Jinyu Yu ◽  
Zhentong Wei ◽  
...  

Well-differentiated papillary mesothelioma (WDPM) is an uncommon mesothelial tumor. The lesions may be single or multiple and usually behave in a benign or indolent fashion, sometimes persisting for many years. In the present case, a 37-year-old woman had experienced primary infertility for 12 years, and a diagnostic laparoscopy was performed. Approximately 200 mL of dark red, free fluid in the pelvis and more than 10 yellow-white nodules on the surface of the right round ligament, sacrum ligament, right fallopian tube, and both sides of the uterus were found. A lesionectomy was performed and immunohistochemical markers indicated WDPM with adenomatoid tumor. The patient was monitored by computed tomography and serum CA125 (cancer antigen 125) levels for 49 months with no recurrence. WDPM and adenomatoid tumor are both benign tumors of mesothelial origin. Because of the lack of effective radical treatment, regular follow-up is sufficient. However, the effects of estrogen and progesterone on WDPM and adenomatoid tumors during ovulation or pregnancy remains unclear. Although WDPM is not life threatening, a strategy to fulfill the fertility requirements of women with this condition is a new challenge for infertility doctors.


2016 ◽  
Vol 27 ◽  
pp. ix98
Author(s):  
T. Ebata ◽  
M. Yunokawa ◽  
S. Bun ◽  
E. Noguchi ◽  
A. Shimomura ◽  
...  

SpringerPlus ◽  
2016 ◽  
Vol 5 (1) ◽  
Author(s):  
Xu Cheng ◽  
Hong-feng Gou ◽  
Ji-yan Liu ◽  
De-yun Luo ◽  
Meng Qiu

2007 ◽  
Vol 107 (3) ◽  
pp. 513-517 ◽  
Author(s):  
Gloria S. Huang ◽  
Lydia G. Chiu ◽  
Juliana S. Gebb ◽  
Marc J. Gunter ◽  
Paniti Sukumvanich ◽  
...  

Author(s):  
Fahri Öçer ◽  
Tugan Beşe ◽  
Ertan Saridoǧan ◽  
Kiliç Aydinli ◽  
Turgay Atasü

1984 ◽  
Vol 148 (8) ◽  
pp. 1057-1058 ◽  
Author(s):  
Jonathan M. Niloff ◽  
Thomas L. Klug ◽  
Elena Schaetzl ◽  
Vincent R. Zurawski ◽  
Robert C. Knapp ◽  
...  
Keyword(s):  

2015 ◽  
Vol 12 (1) ◽  
pp. 55-62
Author(s):  
Baghdad Science Journal

Epithelial ovarian cancer is the leading cause of cancer deaths in women. To date, an effective screening tool for ovarian cancer has not been identified Several clinical and biological factors including serum cancer antigen 125 (CA- 125) have been assessed for prognostic and predictive relevance CA-125 is an epithelial marker derived from coelomic epithelium. It is elevated in 90% of advanced ovarian cancers and in 50% of early ovarian cancers while 20% of ovarian cancers have low or no expression of CA- 125 CA-125 concentrations were measured by Mini Vidas test (VIDAS CA125 II / BIOMERIEUX / France). The median CA-125 levels were significantly higher in the sera of ovarian cancer patients than in those with benign tumors and in healthy controls. However in correlation with stages the results showed that Patients with stage II have highly significant differences in level of serum CA125 compare with stage I in and stage III.CA125 showed low sensitivity to detect stage I carcinoma of the ovary which limits its value as an initial screening tool therefore combining of CA125 with other markers might enable improved early detection of ovarian cancer as compared with use of this marker alone.


1999 ◽  
Vol 10 (3) ◽  
pp. 300
Author(s):  
Ho Jin Chae ◽  
Sung Hong Yang ◽  
Young Do Ahn ◽  
Ki Heung Kim ◽  
Gi Joo Kang

Sign in / Sign up

Export Citation Format

Share Document